The history of GLP-1 drugs is still being written, but one thing is clear these therapies have already firmly established themselves as a cornerstone of metabolic disease management, changing the standard of care and offering hope for a healthier future for many
Do not attempt to make up the skipped shot
Under the agreement: Hansoh will receive a $80 million upfront payment Up to $1.93 billion in development, regulatory, and commercialization milestones Plus double-digit royalties on future global sales This marks another major milestone in the internationalization of Chinas innovative biopharma industry
Your provider may consider further dose adjustment if you are not yet at the maximum dose, evaluate for proper injection technique and medication storage, or assess for other factors affecting treatment response
Why GLP-1 patients need a different calorie approach Standard calorie calculators tell you to eat less
Monitoring for adverse effects from either treatment should continue as normal